Price (delayed)
$2.05
Market cap
$447.27M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.23
Enterprise value
$456.54M
Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. The Company was founded in 2007 and is
There are no recent dividends present for AKBA.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.